Initial Evidence in Thromboangiitis Obliterans (buerger’s Disease) Treatment with Bosentan
نویسندگان
چکیده
Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal ischaemic lesions and digital necrotic ulcers, as well as major amputation rates, among these patients are not negligible. So far, no treatment option has been demonstrated to be completely effective for this disease. Endothelin-1 (ET-1) has been increasingly associated to vascular damage. Furthermore, elevated levels of ET-1 have been proved in TAO patients. Thus, ET-1 receptor antagonists may be considered as a treatment option in this disease. Consistently, initial results from open-label studies or case reports show promising efficacy of bosentan for treatment and prevention of digital ulcers in TAO with a favourable safety profile. In any case, bosentan should be further investigated in TAO patient management. To confirm initial promising findings, larger controlled randomised trials with a control group are needed. In the meantime, bosentan should be considered as a hopeful investigational agent for treating these patients.
منابع مشابه
Buerger’s disease: providing integrated care
Buerger's disease, also known as thromboangiitis obliterans (TAO), is a segmental inflammatory disease affecting small- and medium-sized vessels, which is strongly associated with tobacco use. Although the etiology is still unknown, recent studies suggest an immunopathogenesis. Diagnosis is based on clinical and angiomorphologic criteria, including age, history of smoking, clinical presentation...
متن کاملTreatment of thromboangiitis obliterans (Buerger's disease) with bosentan
BACKGROUND This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease) patients. METHODS A clinical pilot study was designed in which patients with ulcer and/or pain at rest were treated with bosentan p.o. at a dose of 62.5 mg twice daily during the first month, which was thereafter up-titrated to 125 mg twice daily. The stu...
متن کاملSuccessful sequential drug eluting balloon angioplasty to chronic total occluded popliteal artery in a patient with thromboangitis obliterans by PCR
Thromboangitis obliterans (TAO), also known as Buerger’s disease (BD), is a non-atherosclerotic, segmental, inflammatory, episodic, non-destructive, thrombotic, and occlusive disease of unknown origin compromising small to medium-sized distal arteries, veins, and nerves (1). Intravenous iloprost (2), intermittent pneumatic compression (3), bosentan (4), and cilostazol (5) are used or experiment...
متن کاملVascular Medicine Buerger’s Disease (Thromboangiitis Obliterans) — Symptoms and Treatment
In today's world, smoking is very common, and it is considered as a status symbol. Use of different kinds of tobacco in cigarettes and cigars is becoming a fashion. But most people are unaware of how critical this is for the development of cancerous ulcers. Almost five out of every 10 patients of Buerger's syndrome are smokers. Buerger tried to find the root cause of this particular problem. He...
متن کامل